KIN - Kindred Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts8788
Avg. Estimate-0.36-0.34-1.54-1.3
Low Estimate-0.43-0.45-1.62-1.59
High Estimate-0.12-0.11-1.27-0.29
Year Ago EPS-0.46-0.42-1.6-1.54
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts7698
Avg. Estimate1.3M1.75M4.84M10.85M
Low Estimate1.1M1.3M4M7.7M
High Estimate1.5M2.6M10.3M14.4M
Year Ago Sales1.33M1.9M1.97M4.84M
Sales Growth (year/est)-2.00%-7.90%146.20%124.20%
Earnings History2018-12-302019-03-302019-06-292019-09-29
EPS Est.-0.44-0.41-0.38-0.37
EPS Actual-0.46-0.42-0.37-0.39
Difference-0.02-0.010.01-0.02
Surprise %-4.50%-2.40%2.60%-5.40%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.36-0.34-1.54-1.3
7 Days Ago-0.36-0.33-1.52-1.22
30 Days Ago-0.37-0.33-1.52-1.25
60 Days Ago-0.37-0.33-1.52-1.23
90 Days Ago-0.37-0.33-1.52-1.23
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 Days2212
Up Last 30 Days2212
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days4345
Growth EstimatesKINIndustrySectorS&P 500
Current Qtr.21.70%N/AN/A0.02
Next Qtr.19.00%N/AN/A0.05
Current Year3.80%N/AN/A-0.03
Next Year15.60%N/AN/A0.14
Next 5 Years (per annum)40.00%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A